Craig W. Hendrix

23.8k total citations · 1 hit paper
259 papers, 9.8k citations indexed

About

Craig W. Hendrix is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Craig W. Hendrix has authored 259 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 194 papers in Infectious Diseases, 120 papers in Virology and 98 papers in Epidemiology. Recurrent topics in Craig W. Hendrix's work include HIV/AIDS Research and Interventions (154 papers), HIV Research and Treatment (120 papers) and HIV/AIDS drug development and treatment (82 papers). Craig W. Hendrix is often cited by papers focused on HIV/AIDS Research and Interventions (154 papers), HIV Research and Treatment (120 papers) and HIV/AIDS drug development and treatment (82 papers). Craig W. Hendrix collaborates with scholars based in United States, South Africa and Uganda. Craig W. Hendrix's co-authors include Mario Clerici, Edward J. Fuchs, Stephen P. Blatt, Thomas A. Wynn, Mark A. Marzinke, Namandjé N. Bumpus, Gene M. Shearer, Charles Flexner, Jay A. Berzofsky and Pamela A. Lipsett and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Craig W. Hendrix

252 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

2013 1.1k citations Marcel E. Curlin, Craig W. Hendrix et al. profile →

Peers

Countries citing papers authored by Craig W. Hendrix

Since Specialization

Citations

This map shows the geographic impact of Craig W. Hendrix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig W. Hendrix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig W. Hendrix more than expected).

Fields of papers citing papers by Craig W. Hendrix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig W. Hendrix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig W. Hendrix. The network helps show where Craig W. Hendrix may publish in the future.

Co-authorship network of co-authors of Craig W. Hendrix

This figure shows the co-authorship network connecting the top 25 collaborators of Craig W. Hendrix. A scholar is included among the top collaborators of Craig W. Hendrix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig W. Hendrix. Craig W. Hendrix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention 2024 ·The Journal of Infectious Diseases ·Sharon A. Riddler, Clifton W. Kelly, Craig Hoesley, Ken Ho, Jeanna Piper, (unknown), (unknown), Gustavo F. Doncel, Sherri Johnson, Peter L. Anderson, Rhonda M. Brand, Ratiya Pamela Kunjara Na Ayudhya, José A. Bauermeister, Sharon L. Hillier, Craig W. Hendrix	1
2	High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study 2023 ·PLoS Medicine ·Lynn T. Matthews, Esther C. Atukunda, (unknown), (unknown), Christina Psaros, (unknown), Craig W. Hendrix, Mark A. Marzinke, Peter L. Anderson, Oluwaseyi O. Isehunwa, (unknown), Kara Bennett, Winnie Muyindike, David R. Bangsberg, Jessica E. Haberer, Jeanne Marrazzo, Mwebesa Bwana	16
3	Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques 2022 ·JCI Insight ·Peng Xiao, Sanjeev Gumber, Mark A. Marzinke, Thuy Hoang, (unknown), Abhijit A. Date, Justin Hanes, Laura M. Ensign, Lin Wang, Lisa C. Rohan, Richard A. Cone, Edward J. Fuchs, Craig W. Hendrix, François Villinger	1
4	Combining information to estimate adherence in studies of pre‐exposure prophylaxis for HIV prevention: Application to HPTN 067 2022 ·Statistics in Medicine ·James P. Hughes, Brian D. Williamson, (unknown), Gordon Chau, (unknown), Jon Wakefield, Craig W. Hendrix, K. Rivet Amico, Timothy H. Holtz, Linda‐Gail Bekker, Robert M. Grant	1
5	Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305 2021 ·Journal of Antimicrobial Chemotherapy ·Todd T. Brown, Krista Yuhas, Kenneth H. Mayer, Raphael J. Landovitz, Mark A. Marzinke, Craig W. Hendrix, Ying Qing Chen, (unknown), Wairimu Chege, Marybeth McCauley, Roy M. Gulick, Timothy Wilkin	4
6	Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States 2021 ·Journal of the International AIDS Society ·Albert Liu, (unknown), Holly Gundacker, Blažej Neradilek, Craig Hoesley, Ariane van der Straten, Craig W. Hendrix, May A. Beamer, Cindy Jacobson, (unknown), Tanya M. Harrell, Katherine Bunge, Bríd Devlin, Jeremy Nuttall, Patrick Spence, John Steytler, Jeanna Piper, Mark A. Marzinke, (unknown)	17
7	An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil Fumarate 2021 ·AIDS Research and Human Retroviruses ·Ian McGowan, Ratiya Pamela Kunjara Na Ayudhya, Rhonda M. Brand, Mark A. Marzinke, Craig W. Hendrix, Sherri Johnson, Jeanna Piper, Timothy H. Holtz, Marcel E. Curlin, Anupong Chitwarakorn, Boonyos Raengsakulrach, Gustavo F. Doncel, Jill L. Schwartz, James F. Rooney, Ross Cranston, (unknown)	9
8	Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial 2020 ·Journal of the International AIDS Society ·Elizabeth R. Brown, Craig W. Hendrix, Ariane van der Straten, Flavia Matovu Kiweewa, Nyaradzo Mgodi, Thesla Palanee‐Phillips, Mark A. Marzinke, Linda‐Gail Bekker, Lydia Soto‐Torres, Sharon L. Hillier, Jared M. Baeten, (unknown)	50
9	Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: A First-In-Human Study 2020 ·AIDS Research and Human Retroviruses ·(unknown), Eugenie Shieh, Edward J. Fuchs, Mark A. Marzinke, Rahul P. Bakshi, (unknown), Anthony S. Ham, Karen W. Buckheit, (unknown), (unknown), Huan Chen, Brian Caffo, Robert W. Buckheit, Craig W. Hendrix	6
10	Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa 2019 ·BMJ Open ·Lynn T. Matthews, Manjeetha Jaggernath, Yolandie Kriel, Patricia M. Smith, (unknown), Jessica E. Haberer, Craig W. Hendrix, Jared M. Baeten, Norma C. Ware, Kathleen E. Wirth, Christina Psaros, David R. Bangsberg, Jennifer Smit	15
11	Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States 2017 ·AIDS and Behavior ·Elizabeth Montgomery, Lisa Noguchi, James Y. Dai, Jason Pan, Joseph Biggio, Craig W. Hendrix, (unknown), D. Heather Watts, Jill L. Schwartz, Jeanna Piper, Richard H. Beigi	7
12	Lubricant Provides Poor Rectal Mucosal HIV Coverage 2017 ·AIDS Research and Human Retroviruses ·Eugenie Shieh, (unknown), Edward J. Fuchs, (unknown), Karen W. Buckheit, Robert W. Buckheit, (unknown), Craig W. Hendrix	8
13	A Pilot Study Measuring the Distribution and Permeability of a Vaginal HIV Microbicide Gel Vehicle Using Magnetic Resonance Imaging, Single Photon Emission Computed Tomography/Computed Tomography, and a Radiolabeled Small Molecule 2015 ·AIDS Research and Human Retroviruses ·Edward J. Fuchs, Jill L. Schwartz, David R. Friend, Jenell S. Coleman, Craig W. Hendrix	5
14	Simultaneous Evaluation of Safety, Acceptability, Pericoital Kinetics, and Ex Vivo Pharmacodynamics Comparing Four Rectal Microbicide Vehicle Candidates 2015 ·AIDS Research and Human Retroviruses ·Francisco J. Leyva, Edward J. Fuchs, Rahul P. Bakshi, Alex Carballo‐Diéguez, Ana Ventuneac, Yue Chen, Brian Caffo, Yong Du, Michael Torbenson, Liye Li, Gerard E. Mullin, Linda Lee, Lisa C. Rohan, Peter A. Anton, Craig W. Hendrix	10
15	Increasing Extracellular Protein Concentration Reduces Intracellular Antiretroviral Drug Concentration and Antiviral Effect 2013 ·AIDS Research and Human Retroviruses ·Lindsay B. Avery, Melissa Zarr, Rahul P. Bakshi, Robert F. Siliciano, Craig W. Hendrix	9
16	A Randomized Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures (MTN 012/IPM 010) 2013 ·AIDS Research and Human Retroviruses ·Ross Cranston, Craig Hoesley, Alex Carballo‐Diéguez, Craig W. Hendrix, Marla Husnik, Lisa Levy, Wayne Hall, Lydia Soto-Torres, Annaléne Nel	7
17	The clinical pharmacology of antiretrovirals for HIV prevention 2012 ·Current Opinion in HIV and AIDS ·Craig W. Hendrix	20
18	Real-time molecular epidemiologic analysis of an outbreak of Streptococcus pyogenes invasive disease in US Air Force trainees. 1994 ·PubMed ·James M. Musser, Vivek Kapur, John E. Peters, Craig W. Hendrix, (unknown), Gary D. Gackstetter, (unknown), (unknown), (unknown), Lingling Li, (unknown)	27
19	Brucella abortus Stimulates Human T Cells from Uninfected and HIV-infected Individuals to Secrete IFNγ: Implications for Use of Brucella abortus as a Carrier in Development of Human Vaccines 1992 ·AIDS Research and Human Retroviruses ·(unknown), Diana Hernandez, Michael R. Betts, Mario Clerici, (unknown), Craig W. Hendrix, Thomas Hoffman, Basil Golding	15
20	Reconstitution of Long-Term T Helper Cell Function after Zidovudine Therapy in Human Immunodeficiency Virus-Infected Patients 1992 ·The Journal of Infectious Diseases ·Mario Clerici, Alan Landay, Harold A. Kessler, John Phair, David Venzon, Craig W. Hendrix, Daniel R. Lucey, Gene M. Shearer	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact